| [1] |
Rini BI, Campbell SC, Escudier B. Renal cell carcinoma[J]. Lancet, 2009, 373(9669): 1119-1132.
|
| [2] |
Escudier B, Eisen T, Porta C, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2012, 23(Suppl 7): vii65-vii71.
|
| [3] |
Katsanos K, Mailli L, Krokidis M, et al. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours[J]. Cardiovasc Intervent Radiol, 2014, 37(2): 427-437.
|
| [4] |
Crepel M, Jeldres C, Perrotte P, et al. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment[J]. Urology, 2010, 75(2): 271-275.
|
| [5] |
Scosyrev E, Messing EM, Sylvester R, et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904[J]. Eur Urol, 2014, 65(2): 372-377.
|
| [6] |
Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update[J]. Eur Urol, 2015, 67(5): 913-924.
|
| [7] |
Woldrich JM, Palazzi K, Stroup SP, et al. Trends in the surgical management of localized renal masses: thermal ablation, partial and radical nephrectomy in the USA, 1998-2008[J]. BJU Int, 2013, 111(8): 1261-1268.
|
| [8] |
González J, Cózar JM, Gómez A, et al. Nephron-sparing surgery in renal cell carcinoma: current perspectives on technical issues[J]. Curr Urol Rep, 2015, 16(2): 6.
|
| [9] |
Kim SP, Campbell SC, Gill I, et al. Collaborative review of risk benefit trade-offs between partial and radical nephrectomy in the management of anatomically complex renal masses[J]. Eur Urol, 2017, 72(1): 64-75.
|
| [10] |
Kaushik D, Kim SP, Childs MA, et al. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors[J]. Eur Urol, 2013, 64(4): 600-606.
|
| [11] |
Capitanio U, Terrone C, Antonelli A, et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function[J]. Eur Urol, 2015,67(4): 683-689.
|
| [12] |
Kutikov A, Egleston BL, Wong YN, et al. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram[J]. J Clin Oncol, 2010, 28(2): 311-317.
|
| [13] |
Rendon RA. Active surveillance as the preferred management option for small renal masses[J]. Can Urol Assoc J, 2010,4(2):136-138.
|
| [14] |
Pierorazio PM, Johnson MH, Ball MW, et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry[J]. Eur Urol, 2015, 68(3):408-415.
|
| [15] |
Guethmundsson E, Hellborg H, Lundstam S, et al. Swedish kidney cancer quality register G. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish kidney cancer quality register data[J]. Eur Urol, 2011, 60(5): 975-982.
|
| [16] |
Gkentzis A, Oades G. Thermal ablative therapies for treatment of localised renal cell carcinoma: a systematic review of the literature[J]. Scott Med J, 2016, 61(4): 185-191.
|
| [17] |
Caviezel A, Terraz S, Becker CD, et al. Minimally invasive ablation techniques for small kidney tumors: cryoablation and radiofrequency[J]. Revue medicale suisse, 2018, 4(182): 2642-2647.
|
| [18] |
Mo Z, Lu H, Mo S, et al. Ultrasound-guided radiofrequency ablation enhances natural killer-mediated antitumor immunity against liver cancer[J]. Oncol Lett, 2018, 15(5): 7014-7020.
|
| [19] |
Kelly EF, Leveillee RJ. Image guided radiofrequency ablation for small renal masses[J]. Int J Surg, 2016, 36(Pt C): 525-532.
|
| [20] |
Bopp S. Percutaneous ct-guided radiofrequency ablation of solitary small renal masses: a single center experience[J]. Fortschr Rntgenstr, 2015, 187(7): 577-583.
|
| [21] |
Xiaobing W, Wentao G, Guangxiang L, et al. Comparison of radiofrequency ablation and partial nephrectomy for tumor in a solitary kidney[J]. Bmc Urology, 2017, 17(1): 79.
|
| [22] |
Kuo WT, Yuan LH, Chen YS, et al. Comparison of partial nephrectomy and percutaneous radiofrequency ablation for small renal masses in the manner of preoperative aspects and dimensions used for an anatomical (padua) classification[J]. Urol Sci, 2016, 195(4): e346-e347.
|
| [23] |
Lay AH, Faddegon S, Olweny EO, et al. Oncologic efficacy of Radiofrequency Ablation for Small Renal Masses: Clear Cell versus Papillary Subtype[J]. J Urol, 2015, 194(3): 653.
|
| [24] |
José LF, Sílvia H, Berdejo J, et al. Treatment failure after image-guided percutaneous radiofrequency ablation (rfa) of renal tumors-a systematic review with description of type, frequency, risk factors and management[J]. RöFo - Fortschritte auf dem Gebiet der R, 2017, 189(3): 219-227.
|
| [25] |
Wah TM, Irving HC, Gregory W, et al. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours[J]. BJU Int, 2014, 113(3): 416-428.
|
| [26] |
Christensen SF, Hansen JM. Donor kidney with renal cell carcinoma successfully treated with radiofrequency ablation: a case report[J]. Transplant Proc, 2015, 47(10): 3031-3033.
|
| [27] |
Menezes MR, Viana PC, Yamanari TR, et al. Safety and feasibility of radiofrequency ablation for treatment of bosniak iv renal cysts[J]. Int Braz J Urol, 2016, 42(3): 456-463.
|
| [28] |
Rivero JR, De La CJ 3rd, Wang H, et al. Partial nephrectomy versus thermal ablation for clinical stage t1 renal masses: systematic review and meta-analysis of more than 3,900 patients[J]. J Vasc Interv Radiol, 2018, 29(1): 18-29.
|
| [29] |
Muto G, Castelli E, Migliari R, et al. Laparoscopic microwave ablation and enucleation of small renal masses: preliminary experience[J]. Eur Urol, 2011, 60(1): 173-176.
|
| [30] |
Takaki H, Imai N, Thomas CT, et al. Changes in peripheral blood T-cell balance after percutaneous tumor ablation[J]. Minim Invasive Ther Allied Technol, 2017, 26(6): 331-337.
|
| [31] |
Aarts BM, Prevoo W, Meier MAJ, et al. Percutaneous microwave ablation of histologically proven t1 renal cell carcinoma[J]. Cardiovasc Intervent Radiol, 2020, 43(7): 1025-1033.
|
| [32] |
Guo J, Arellano RS. Percutaneous microwave ablation of stage t1b renal cell carcinoma: short-term assessment of technical feasibility, short-term oncologic outcomes, and safety[J]. J Endourol, 2020, 34(10): 1021-1027.
|
| [33] |
Hao G, Hao Y, Cheng Z, et al. Local tumor progression after ultrasound-guided percutaneous microwave ablation of stage T1a renal cell carcinoma: risk factors analysis of 171 tumors[J]. Int J Hyperthermia, 2018, 35(1): 62-70.
|
| [34] |
Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: aua guideline[J]. J Urol, 2017, 198(3): 520-529.
|
| [35] |
Lin Y, Liang P, Yu XL, et al. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with renal dysfunction[J]. Int J Hyperthermia, 2017, 33(4): 440-445.
|
| [36] |
Lin Y, Liang P, Yu XL, et al. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney[J]. Urology, 2014, 83(2): 357-363.
|
| [37] |
Yu J, Zhang X, Liu H, et al. Percutaneous microwave ablation versus laparoscopic partial nephrectomy for ct1a renal cell carcinoma: a propensity-matched cohort study of 1955 patients[J]. Radiology, 2020, 294(3): 698-706.
|
| [38] |
Yu J, Liang P, Yu XL, et al. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results[J]. Radiology, 2012,263(3):900-908.
|
| [39] |
Thompson SM, Schmitz JJ, Thompson RH, et al. Introduction of microwave ablation into a renal ablation practice: valuable lessons learned[J]. AJR Am J Roentgenol, 2018, 211(6): 1381-1389.
|
| [40] |
Farrag K, Sriprasad S. Non-surgical ablative therapy for management of small renal masses-current status and future trends[J]. Indian J Surg Oncol, 2017, 8(1): 39-45.
|
| [41] |
Bhagavatula SK, Tuncali K, Shyn PB, et al. Percutaneous ct- and mri-guided cryoablation of ct1 renal cell carcinoma: intermediate- to long-term outcomes in 307 patients[J]. Radiology,2020,296(3):687-695.
|
| [42] |
Altunrende F, Autorino R, Hillyer S, et al. Image guided percutaneous probe ablation for renal tumors in 65 solitary kidneys: functional and oncological outcomes[J]. J Urol, 2011, 186(1): 35-41.
|
| [43] |
Kim SH, Joung JY, Seo HK, et al. Baseline chronic kidney disease and ischemic method of partial nephrectomy are important factors for the short- and long-term deterioration in renal function for renal cell carcinoma staged t1-t2: a retrospective single center study[J]. Biomed Res Int, 2016, 2016: 5398381.
|
| [44] |
Sriprasad S, Aldiwani M, Pandian S, et al. Renal Function Loss After Cryoablation of Small Renal Masses in Solitary Kidneys: European Registry for Renal Cryoablation Multi-Institutional Study[J]. J Endourol, 2020, 34(2): 233-239.
|
| [45] |
Sriprasad S, Aldiwani M, Pandian S, et al. Renal Function Loss After Cryoablation of Small Renal Masses in Solitary Kidneys: European Registry for Renal Cryoablation Multi-Institutional Study[J]. J Endourol, 2020, 34(2): 233-239.
|
| [46] |
Pecoraro A, Palumbo C, Knipper S, et al. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer[J]. J Urol, 2019, 202(6): 1120-1126.
|
| [47] |
Marion JT, Schmitz JJ, Schmit GD, et al. Safety and efficacy of retrograde pyeloperfusion for ureteral protection during renal tumor cryoablation[J]. J Vasc Interv Radiol. 2020, 31(8): 1249-1255.
|
| [48] |
Yin X, Cui L, Li F, et al. Radiofrequency ablation versus partial nephrectomy in treating small renal tumors: a systematic review and meta-analysis[J]. Medicine, 2015, 94(50): e2255.
|
| [49] |
Yang Y, Chen S, Chen F, et al. Outcome of radiofrequency ablation over partial nephrectomy for small renal mass (<4 cm): a systematic review and meta-analysis[J]. Int J Clin Exp Med, 2015, 8(11): 20670-20674.
|